Understanding Velcade (bortezomib) for Injection
Velcade® (bortezomib) is a proteasome inhibitor that plays a role throughout the myeloma disease course, from induction therapy for the newly diagnosed, to a possible role as part of conditioning for stem cell transplant, to consolidation/maintenance therapy, to treatment for those whose myeloma has relapsed or become refractory.
*updated 5/15/2023